Description: Update on statutory Valuation reserves and required surplus for variable annuities with living benefit guarantees

Description: This presentation is an open forum, session number 12OF, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The National Association of Insurance Commissioners [NAIC] has proposed a requirement that certain products have risk-based capital [RBC] C-3 determined as the greater of a calculation based on fixed factors, and results of a formalized cash-flow test. The panelists provide a summary of the requirements of C-3 testing, followed by an open discussion regarding implementation issues and other questions.

Description: From a teaching session at the 2001 Valuation Actuary Symposium, held in Lake Buena Vista, Florida, November 29-30, 2001 Discussion of the requirements under statutory codification that are of interest to actuaries. Topics included: • Policy classification • Deferred taxes • Accident and health issues • Disclosure • State differences • Implementation issues

Description: This presentation is an Interactive Forum, session number 20IF, from the 1999 Valuation Actuary Symposium, held September 23-24 in Los Angeles. The panelists discuss the American Academy’s Valuation Task Force and its committees working on the proposal to revise the Standard Valuation Law, referred to as the Unified Valuation Law [UVL], to update participants as to the status of the committees’ work. They provide a description of the activities currently taking place, and an update of where the revisions process stands and what the next steps are. The current system versus what is proposed are discussed, including concerns of regulators. Discussion from participants is included.

Description: 2003 Valuation Actuary Symposium, San Diego, CA. This panel of appointed actuaries shared their perspectives and practical experiences in fulfilling the duties and responsibilities of the appointed actuary with the goal of providing a better understanding of the duties and responsibilities of the appointed actuary, supporting actuaries and staff.

Description: 1988 Valuation Actuary Symposium. In this session the speaker described the attributes of a UL policy, how his company invested the cash that was built up, valuation of the product, modeling in general, the specific model structure for Universal Life, problems encountered in the modeling process, and some of the more interesting aspects of the results.

Description: This presentation is a panel discussion, session number 2PD, from the 2000 Valuation Actuary Symposium, held September 14-15 in Washington, DC. The panelists provide an overview of current statutory valuation issues pertaining to life and annuity products, to be covered in-depth at subsequent sessions. Topics include: new valuation table for life insurance NAIC Actuarial Guidelines [AG] for variable product guaranteed living benefits and for equity-indexed universal life [ZZZZ] amendments to the Actuarial Opinion and Memorandum Regulation [AOMR] progress on Unified Valuation System [UVS] Model Regulations on Separate Accounts Funding Group Contracts with Guarantees, and on Synthetic Guaranteed Investment Contracts [GICs] regulatory concern over liquidity and Regulation XXX mortality X factors.

Description: 1988 Valuation Actuary Symposium. In this session the speaker described the modeling of the participating whole life division including the product description, modelling assumptions, operation of the model, and the results.

Description: Presented at October 1996 Annual Meeting. This discussion looks at recent developments and emerging issues with the NAIC.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 The National Association of Insurance Commissioners NAIC Valuation of Life Insurance Policies Model Regulation XXX sets forth the valuation requirements for life insurance with nonlevel premiums or nonlevel benefits, including term insurance and universal life with certain underlying guarantees. Panelists discussed the issues around implementation of the requirements. The issues discussed include: • Determination of X factors when no credible company mortality exists • Proper treatment of secondary guarantees in universal life insurance • Preparation of the mortality assumption opinion requirements • Impacts on product development and design